These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28612153)

  • 1. Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland.
    Sihvonen R; Siira L; Toropainen M; Kuusela P; Pätäri-Sampo A
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2109-2116. PubMed ID: 28612153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
    Neves FPG; Cardoso NT; Snyder RE; Marlow MA; Cardoso CAA; Teixeira LM; Riley LW
    Vaccine; 2017 May; 35(21):2794-2800. PubMed ID: 28431817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria.
    Setchanova L; Murdjeva M; Stancheva I; Alexandrova A; Sredkova M; Stoeva T; Yoneva M; Kurchatova A; Mitov I
    Braz J Infect Dis; 2017; 21(4):433-440. PubMed ID: 28472614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in relation to sero- and genotypes among invasive Streptococcus pneumoniae in Finland, 2007-2011.
    Siira L; Jalava J; Kaijalainen T; Ollgren J; Lyytikäinen O; Virolainen A
    Microb Drug Resist; 2014 Apr; 20(2):124-30. PubMed ID: 24266666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
    J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program.
    Miyazaki H; Shibuya R; Midorikawa N; Chang B; Ohnishi M; Matsumoto T
    J Infect Chemother; 2017 Apr; 23(4):234-240. PubMed ID: 28161295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine.
    Setchanova LP; Alexandrova A; Mitov I; Nashev D; Kantardjiev T;
    J Chemother; 2012 Feb; 24(1):12-7. PubMed ID: 22546719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
    Cassiolato AP; Almeida SCG; Andrade AL; Minamisava R; Brandileone MCC
    PLoS One; 2018; 13(11):e0208211. PubMed ID: 30496296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland.
    Polkowska A; Skoczyńska A; Paradowska-Stankiewicz I; Stefanoff P; Hryniewicz W; Kuch A; Lyytikäinen O; Nuorti JP
    Vaccine; 2019 Feb; 37(10):1365-1373. PubMed ID: 30638798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.
    Brandileone MC; Casagrande ST; Guerra MLS; Zanella RC; Andrade ASS; Fabio JD
    J Med Microbiol; 2006 May; 55(Pt 5):567-574. PubMed ID: 16585644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    Hjálmarsdóttir MÁ; Quirk SJ; Haraldsson G; Erlendsdóttir H; Haraldsson Á; Kristinsson KG
    PLoS One; 2017; 12(1):e0169210. PubMed ID: 28125588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
    Miller E; Andrews NJ; Waight PA; Slack MP; George RC
    Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.